Sharp Corp presented at COSME TOKYO 2016 developed a sensor that quantifies the accumulation of advanced glycation endproducts (AGEs).
The company exhibited a prototype of the sensor, “Blood Vessel Aging Degree Sensor,” at Semicon Japan 2014, which took place from Dec 3 to 5, 2014, in Tokyo. It can visualize the degree of aging of blood vessels, which cannot be measured by conventional blood glucose level sensors. It enables to detect diabetes, etc at an early stage. Sharp aims to commercialize it in the second half of fiscal 2015.
When too much sugar is taken in daily life, protein is saccharified and becomes incapable of functioning normally. This is called glycation and allegedly causes not only diabetes but dementia, cancers, high blood pressure, arteriosclerosis, etc. In other words, AGEs are the source of all kinds of diseases.
AGEs are known to have a correlation with blood glucose level. But, unlike blood glucose level, their measurement values do not fluctuate much depending on, for example, the meal taken before the measurement.